610 results match your criteria: "Laboratory of Clinical Pharmacy.[Affiliation]"

Gut microbiota and inflammasome-mediated pyroptosis: a bibliometric analysis from 2014 to 2023.

Front Microbiol

January 2025

Department of Clinical Pharmacy, Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi, China.

Background: The role of gut microbiota in inflammatory disease development and progression has been recognized more recently. Inflammasome-mediated pyroptosis in involved in these diseases. This complex relationship between gut microbiota and inflammasome-mediated pyroptosis provides an important field of research.

View Article and Find Full Text PDF

Outer membrane vesicles (OMVs), shed by Gram-negative bacteria, are spherical nanostructures that play a pivotal role in bacterial communication and host-pathogen interactions. Comprising an outer membrane envelope and encapsulating a variety of bioactive molecules from their progenitor bacteria, OMVs facilitate material and informational exchange. This review delves into the recent advancements in OMV research, providing a comprehensive overview of their structure, biogenesis, and mechanisms of vesicle formation.

View Article and Find Full Text PDF

Pharmacokinetics, mass balance, and metabolism of [C]PLB1004, a selective and irreversible EGFR-TKI in humans.

Cancer Chemother Pharmacol

January 2025

Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Jinan, 250014, China.

Purpose: PLB1004, developed by Beijing Avistone Biotechnology Co., Ltd., is a safe, highly selective, and efficient irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) employed in treating non-small-cell-lung-cancer (NSCLC).

View Article and Find Full Text PDF

Pharmacokinetic Interaction between Imatinib and Tacrolimus in Rats.

Curr Drug Metab

December 2024

Department of Pharmacy, the Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, China.

Objective: Tacrolimus, a calcineurin inhibitor (CNI), is the first-line treatment for chronic myeloid leukemia (CML) and advanced gastrointestinal stromal tumors (GIST). Imatinib and tacrolimus are both substrates of the hepatic enzymes CYP3A4/5 and efflux transporter P-gp, so drug-drug interactions may occur during their co-administration treatment. Therefore, this study aimed to evaluate the pharmacokinetic interaction between imatinib and tacrolimus in rats.

View Article and Find Full Text PDF

Quantification of gimeracil, tegafur, and 5-FU in human plasma via LC-MS/MS with a simplified pretreatment using flow-through extraction.

J Chromatogr B Analyt Technol Biomed Life Sci

January 2025

Laboratory of Clinical Pharmacy and Sciences, School of Pharmacy, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan. Electronic address:

Gimeracil, a component in S-1 (an oral anticancer agent comprising tegafur, a prodrug of 5-fluorouracil (5-FU), potassium oxonate, and gimeracil), inhibits metabolic enzymes, thereby impeding 5-FU degradation. Therefore, the blood level of gimeracil is closely associated with the disposition of 5-FU, and quantification of gimeracil can provide important information if a case shows an inappropriate 5-FU blood concentration. Nevertheless, methods for quantifying gimeracil in human plasma are rarely reported.

View Article and Find Full Text PDF

Effect of furmonertinib on the pharmacokinetics of rivaroxaban or apixaban in vivo.

J Chromatogr B Analyt Technol Biomed Life Sci

January 2025

Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China; Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, China. Electronic address:

Article Synopsis
  • Furmonertinib is a third generation EGFR-TKI used to treat non-small cell lung cancer (NSCLC), which often coexists with venous thromboembolism (VTE) that is treated using direct oral anticoagulants (DOACs) like rivaroxaban and apixaban.
  • This study investigated how furmonertinib affects the pharmacokinetics of these DOACs in rats, revealing that it significantly increases the concentration and overall exposure (C and AUC) of both rivaroxaban and apixaban while decreasing their clearance (CL/F) and volume of distribution (V/F).
  • The findings highlight the importance of recognizing furmonertinib’s impact on
View Article and Find Full Text PDF

Impact of high blood pressure on the risk of mortality among Japanese people aged 65 years and older.

Geriatr Gerontol Int

January 2025

Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.

Aim: The purpose of this study is to investigate the impact of abnormal blood pressure on the risk of all-cause and cardiovascular mortality in a large cohort of older Japanese people aged ≥65 years.

Methods: This cohort study enrolled 54 760 participants from Okayama City aged ≥65 years who underwent basic health checkups from April 2006 to March 2008. Based on blood pressure, the participants were divided into six categories, from C1 (lowest) to C6 (highest).

View Article and Find Full Text PDF
Article Synopsis
  • The CDK4/6 inhibitor palbociclib often causes neutropenia, making it challenging to maintain the standard 3/1 dosing schedule (3 weeks on, 1 week off) for patients with hormone receptor-positive and HER2-negative metastatic breast cancer.
  • A study conducted at Ogaki Municipal Hospital analyzed different dosing schedules and their impact on treatment duration, dose intensity, overall response rate, and adverse events among patients treated from January 2018 to November 2023.
  • Results indicated that alternative dosing schedules (3/2 and 2/2) were associated with longer treatment durations and higher overall response rates compared to the standard 3/1 schedule, suggesting these alternatives may maintain therapeutic effectiveness.
View Article and Find Full Text PDF

Machine learning models for coagulation dysfunction risk in inpatients administered β-lactam antibiotics.

Front Pharmacol

November 2024

Shandong Engineering and Technology Research Center for Pediatric Drug Development, Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.

Article Synopsis
  • β-Lactam antibiotics are commonly used, but their potential to cause coagulation dysfunction highlights the importance of understanding these risks.
  • Machine learning techniques were applied to electronic health record data from over 45,000 adult inpatients to identify risk factors and estimate the likelihood of coagulation issues caused by different β-lactam antibiotics.
  • The study revealed varying incidence rates of coagulation dysfunction for several antibiotics and developed predictive models using machine learning to assess these risks more effectively.
View Article and Find Full Text PDF

Objective: To assess the efficacy and safety of anlotinib combined with immune checkpoint inhibitors (ICIs) in patients with advanced non-small-cell lung cancer (NSCLC).

Methods: Clinical data on patients with advanced NSCLC were collected from June 2019 to October 2022 at Hebei General Hospital, China. The efficacy and safety of anlotinib combined with ICIs and platinum-containing chemotherapy were retrospectively analyzed.

View Article and Find Full Text PDF

Platinum nanozyme embedded in hyaluronate with multifunctional attributes synergistically promoting tracheal fistula healing.

Int J Biol Macromol

January 2025

Department of Pulmonary and Critical Care Medicine, Fujian Key Laboratory of Lung Stem Cell, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.. Electronic address:

Respiratory tract fistulas, including tracheal and bronchial fistulas, usually cause prolonged hospitalization with developed complications and even death, while respiratory tract fistula healing remains challenging. Exploring effectiveness and mechanism in animal systems using well-designed bio-nanomaterials will improve our understanding of fistula management. Hyaluronate (hyaluronan or hyaluronic acid) has been widely studied as a promising coating material for bio-nanomaterials in treatment applications.

View Article and Find Full Text PDF

Amentoflavone for treating cardiocerebrovascular diseases and neurological disorders.

Front Pharmacol

November 2024

Department of Clinical Pharmacy, Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.

Article Synopsis
  • - Amentoflavone (AME) is a flavonoid found in over 120 plants, known for its potential to treat cardiocerebrovascular and neurological diseases, though its poor solubility and bioavailability have limited its development as a therapeutic drug.
  • - This review details AME's chemical structure, extraction methods, and how it interacts with the body, alongside its effects on heart and brain-related disorders, highlighting its pharmacological mechanisms.
  • - To promote AME as a viable treatment option, further research is needed to assess its pharmacokinetics and toxicology to ensure it is safe and effective for medical use.
View Article and Find Full Text PDF

Effects of Flavanone Derivatives on Adipocyte Differentiation and Lipid Accumulation in 3T3-L1 Cells.

Life (Basel)

November 2024

Laboratory of Clinical Pharmacy, School of Pharmacy, Nihon University, 7-7-1, Narashinodai, Funabashi 274-8555, Chiba, Japan.

Flavanones, a class of flavonoids, are abundant in fruits, vegetables, and herbs. They are known to have several biological activities, such as anti-inflammatory and anti-cancer activities, but their effects on obesity remain unclear. Obesity is closely associated with adipocyte differentiation and lipid accumulation in adipose tissue.

View Article and Find Full Text PDF

, esophageal precancerous lesions, and proton pump inhibitor overuse.

World J Gastroenterol

November 2024

Department of Clinical Pharmacy, Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563006, Guizhou Province, China.

This article reviews the cohort study published in the , which reported low rates of () infection among esophageal cancer (EC) patients, coupled with proton pump inhibitor (PPI) overuse. These findings suggest a potential protective role of against EC and indicate a possible association between PPI use and increased cancer risk. In light of these findings, our article examines the complex relationship between and esophageal precancerous lesions, exploring the potential underlying mechanisms.

View Article and Find Full Text PDF

BCDPi: An interpretable multitask deep neural network model for predicting chemical bioconcentration in fish.

Environ Res

January 2025

Shandong Engineering and Technology Research Center for Pediatric Drug Development, Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China. Electronic address:

Article Synopsis
  • A new multitask deep learning model was developed to predict the bioconcentration potential of chemical compounds, categorizing them into non-bioconcentrative, weakly bioconcentrative, and strongly bioconcentrative groups.
  • The model performed well, achieving over 90% accuracy in binary classification and 91.11% accuracy overall for ternary classification.
  • It also provides an online tool (BCdpi-predictor) for users to predict bioconcentration potential and has implications for environmental risk assessment and regulatory frameworks like REACH.
View Article and Find Full Text PDF

Assessment of the modified attitudes toward health care teams scale using item response theory analysis.

J Interprof Care

January 2025

WHO Collaborating Centre for Research and Training on Interprofessional Education, Gunma University, Maebashi, Japan.

Article Synopsis
  • - The modified Attitudes Toward Health Care Teams Scale (mATHCTS) is a reliable 14-item questionnaire designed to evaluate how participants perceive the effects of interprofessional collaboration in health care.
  • - Research using item-response theory (IRT) was conducted on 180 health and welfare university students to analyze the scale's item characteristics like difficulty and discrimination, showing that the mATHCTS is effective in identifying attitudes toward health care teams.
  • - The study found that while the test-response function (TRF) increased consistently with ability, the test-information function (TIF) indicated that measurement accuracy decreased as total scores rose, affirming that the mATHCTS identifies participants with lower scores effectively.
View Article and Find Full Text PDF

The effectiveness and safety of posaconazole enteric-coated tablet versus oral suspension in invasive fungal infections.

Sci Rep

November 2024

Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital Shandong Engineering and Technology Research Center for Pediatric Drug Development, Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Jinan, 250014, China.

Posaconazole enteric-coated tablet and oral suspension are two oral drugs in the treatment of invasive fungal infections (IFIs). This study compared the effectiveness and safety between posaconazole enteric-coated tablet and oral suspension, and provided a real world basis for the clinical practice. A retrospective cohort study was performed on IFIs patients treated with posaconazole enteric-coated tablet or oral suspension.

View Article and Find Full Text PDF

Objectives: In recent years, Japan has experienced a series of earthquakes and torrential rain disasters in various regions, and in Gifu City, there is concern about the possibility ofNankai Trough earthquakes in the near future. However, pharmacists' awareness of disaster preparedness and status of drug stockpiles in pharmacies are not clearly outlined.

Methods: A survey on disaster prevention and stockpiling was conducted in 286 pharmacies in Gifu City.

View Article and Find Full Text PDF

Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease.

World J Gastroenterol

October 2024

Department of Clinical Pharmacy, Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563006, Guizhou Province, China.

Liver diseases pose a significant threat to human health. Although effective therapeutic agents exist for some liver diseases, there remains a critical need for advancements in research to address the gaps in treatment options and improve patient outcomes. This article reviews the assessment of Elafibranor's effects on liver fibrosis and intestinal barrier function in a mouse model of alcoholic liver disease (ALD), as reported by Koizumi in the .

View Article and Find Full Text PDF

Background: Education level significantly impacts individual health outcomes. This research investigates the correlation between education level and the prevalence of overactive bladder (OAB).

Methods: This study employed data from the National Health and Nutrition Examination Survey (NHANES) spanning 2005 to 2020 to conduct a thorough investigation of the association between educational level and OAB using multivariable logistic regression, smooth curve fitting, and generalized additive model.

View Article and Find Full Text PDF

Mucin-Triggered Osmium Nanoclusters as Protein-Corona-Like Nanozymes with Photothermal-Enhanced Peroxidase-Like Activity for Tumor-Specific Therapy.

Nano Lett

November 2024

CAS Engineering Laboratory for Nanozyme, Key Laboratory of Protein and Peptide Pharmaceutical, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

Nanomaterials with peroxidase-like activity and photothermal conversion efficiency have garnered significant attention for their ability to generate cytotoxic hydroxyl radicals and provide synergistic therapeutic effects. Selecting nanozymes with suitable properties and carriers is crucial for maximizing efficacy. While the mucin family is known for its mucoadhesive, glycosylated structures that enhance drug bioavailability and targeting, its potential in nanozymes remains underexplored.

View Article and Find Full Text PDF

Bioequivalence Analysis of Ondansetron Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Two-Period Crossover Phase I Study.

Drugs R D

December 2024

Department of Pharmacy and Hebei Key Laboratory of Clinical Pharmacy, Hebei General Hospital, No. 348 Heping West Road, Xinhua District, Shijiazhuang City, 050051, Hebei Province, People's Republic of China.

Background: Ondansetron is a highly selective 5-HT3 receptor antagonist that alleviates nausea and vomiting. Bioequivalence evaluation ensures that the efficacy of generic drugs is consistent with that of the original drug.

Objective: The objective of this study was to evaluate the bioequivalence of ondansetron hydrochloride (HCl) tablets taken in single doses under fasting and postprandial conditions in healthy subjects.

View Article and Find Full Text PDF

Autoimmune complications of tyrosine kinase inhibitors in cancer therapy: Clinical insights, mechanisms, and future perspectives.

Medicine (Baltimore)

October 2024

Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Jinan, China.

The tyrosine kinase inhibitors (TKIs) have emerged as a promising class of novel anticancer drugs, achieving significant success in clinical applications. However, the risk of autoimmune diseases associated with these drugs has raised widespread concerns. In this review, TKI-induced autoimmune diseases are reviewed in order to understand this complex phenomenon through clinical research and molecular mechanism exploration.

View Article and Find Full Text PDF